P328

NEUROINTERVENTION: CAROTID (23)Objectives: Upon completion of this workshop, theattendee should be able to:

1. Describe the fundamentals of vascular interven­tion involving the carotid artery as approachedby a peripheral vascular interventionalist.

2. Describe the. various lesions and anatomical char­acteristics of the cervical carotid artery and how tosllccessfully gain access and treat these lesions.

3. Describe the various catheters, guide catheters,guidewires, and sCents needed to stent celvicalcarotid lesions.

4. Describe the basics of neufointerventional radi­ology in managing carotid stent complicationssuch as gaining access inca the distal internalcarotid and middle cerebral artery to deliverthrombolytic therapy.

5. Improve on the ability to recruit referrals forcarotid stent placement.

Coordinator: Michael H. \'Vholey, MD

Barry 1'. Katzen, MD Tony P. Smirn, MDGeorge P. Teitelbaum, MD David A. Kumpe, MDMark H. Wholey, MD Gregory joseph, MDGustave Eles, DO Prabhakar Kasava, MDWayne F. Yakes, MD Michael H. Wholey, MD

KJaus D. Malhias, MD

NEUROINTERVENTION: EMBOLIZATION"HANDS-ON" (24)Objectives: Upon completion of this workshop, theattendee should be able to:

1. Become familiar with the vast array of interven­tional!neuroradiologic devices in a hands-onfashion.

2. Determine what uses may be applicable in theirpractice.

Coordinator: Wayne F. Yakes, MD

Richard M. Berger, .MD Charles W. Kerber, MDSteven Hecht, MD Tim Malisch, MDRandaU T. Higashida, MD Alex Bernstein, MD

Wayne F. Yakes, MD

NEUROINTERVENTION: SPINE (25)Objectives, Upon completion of this workshop, theattendee should be able to,

1. Describe the basic anatomy required for theperformance of basic interventional spine tech­niques.

2. Review the historical developments and currenttrends in pain management as it relates to inter­ventional spine techniques.

3. Describe the techniques for interventional spineprocedures including epidural steroid injec­tions, facet blocks, selective nerve root blocks,sacroiliac joint injections, discography, percuta­neous ve.tebroplasty, and IDET.

Coordinator: James Luethke, MD

Joseph R. Steele, MD J. Kevin McGraw, MDjohn M. Mathis, MO, MSc James Luethke, MD

NEUROINTERVENTION: STROKE (26)Objectives: Upon completion of this workshop, theattendee should be able to:

1. Explain the rationale for emergency interven­tional stroke therapy.

2. Describe how to identify appropriate symptomsof patients for emergency stroke therapy,whether medical or interventional.

3. Be familiarized with the NIH Stroke Scale.4. Be able to score a CT scan for evaluation before

emergency stroke therapy.5. Discuss the pharmacokinetics of the various

drugs involved with emergency stroke therapy.6. List the new devices potentially useful for emer­

gency stroke therapy.

Coordinator: J.). "Buddy" Connors, Ill, lvID

Brian Berger, MD Tony P, Smith, MDBemadene Stallmeyer, MD Rodney D. Raabe, MDJohn Perl, MD David A, Kumpe, MDG~lJY M. Nesbit, MD joan Wojak, MOFiras AI-Ali, MD J.J. "Buddy" Connors, III, MD

PEDIATRIC INTERVENTIONS: NONVASCULARTECHNIQUES (2B)Objectives: Upon completion of this workshop, theattendee should be able to:

1. Describe pediatric needle biopsies, pediatric chestdrainage and pediatric orthopedic procedures.

2. Explain the specific indications for appropriateintervention.

3. Describe pediatric-specific techniques neces­sary for successful procedures.

Coordinator: james S. Donaldson, MD

Fredric A. Hoffer, MD Martha C. Saker, MD

Neil D. johnson, .~BS, FRACR

PUNCTURE SITE MANAGEMENT "HANDS-ON" (29)Objectives: Upon completion of this workshop, theattendee should be able to:

1. Discuss currently available puncture site closingdevices

2. Describe the technique of achieving hemostasiswith the various devices.

3. Discuss the indications for using such devices.4. Discuss potential complications associated with

arterial closing devices.5. Review the indications, advantages, and limita­

tions of ultrasound-guided pseudoaneurysmcompression.

6. Determine the role of percutaneous thrombininjection for the management of catheterizationinduced compression.

Martin Crain, MDJacob Cynamon, MDKevin Dickey, MDPeter Drescher, MDPamela Flick, MDKamran Ahrar, MDRobert A. Beres, MDMark W. Mewissen, MDwilliam S. Rilling, MD

Co-Coordinators: Mark W. Mewissen, MDWilliam S. Rilling, MD

Ziv Haskal, MDStephen T. Kee, MDHoornan Khabiri, MDAngelo . Makris, MDThomas O. McNamara, MDFranklin]. Miller, Jr, MDRicardo Paz-Fumagalli, MDGerard]. O'Sullivan, MDMoni Stein, MD

REGIONAL CANCER THERAPY (30)Objectives: Upon completion of this workshop, theattendee should be able to:

1. Select patients for regional cancer therapy basedon clinical, radiologic, and laboratory parameters.

2. Describe the pre-, peri-, and post-proceduralstages of regional cancer therapy, including pre­medication, pain control, and palliation of post­embolization syndrome.

Coordinator: Romi Chopra, MD

Romi Chopra, MD Eric A. Huettl, MDMichael C. Soulen, MD Moni Stein, MDJeff H. Geschwind, MD Julie M. Zaecra, MD

RENOVASCULAR INTERVENTIONS (31)Objectives: Upon completion of this workshop, theattendee should be able to:

1. Discuss the role of noninvasive and angio­graphic evaluation in renovascular disease.

2. Discuss strategies for treating renal artery stenosis.3. Review and discuss percutaneous therapy: a

step by step discussion of the techniques em­phasiZing advantages and disadvantages whenperforming balloon angioplasty and intravascu­lar stenting.

4. Discuss outcomes of percutaneous intervention(Hypertension, renal insufficiency).

5. Discuss complications and their treatment.

Coordinator: David]. Spinosa, MD

Michael A. Betunann, MD Mohsin Saeed, MDJames G. Caridi, MD 1110mas A. $os, MDLouis G. lVlartin, MD David W. Trost, MDAlan H. Ma(Sumoto, MD Tin10thy P. Murphy, MDChet R. Rees, MD Souheil Saddekni, MDJohn H. Rundback, MD David]. Spinosa, MD

INTRAVASCULAR COVERED STENTS ANDSTENT GRAFTS (32)Objectives: Upon completion of this workshop, theattendee should be able to:

1. Discuss endovascular stent-graft applications inthe thoracic aorta and non-aortic vasculatureincluding TIPS and traumatic vascular injuries.

2. Describe the fundamental concepts in custom­izing a simple endovascular stent-graft usingavailable stents and graft material.

3. Discuss the various types of stent-grafts includ­ing self-expanding and balloon expandable de­vices.

4. Discuss the indications, techniques, complica­tions, and regulatory issues involVing stentgrafts.

Coordinator: Charles P. Semba, MD

Stephen T. Kee, MD Charles P. Semba, MDMahmood K. Razavi, MD Daniel Sze, MD, PhD

THROMBOLYSIS-ARTERIAL (34)Objectives: Upon completion of this workshop, theattendee should be able to:

1. Properly select candidates for arterial thrombol­ysis.

2. List the technical aspects of arterial thromboly­sis, including: choice of thrombolytiC agent,dosing regimens, delivery systems.

3. Describe safe and effective protocols for cur­rently available thrombolytic agents.

4. Outline the safe and effective use of associatedmedications, including: anticoagulants andplatelet inhibitors.

5. Explain how to handle complex or difficult sit­uations that may arise during thrombolysis pro­cedures.

6. Discuss patient care issues during and immedi­ately after thrombolytiC therapy.

Coordinator: John E. Aruny, MD

John E. Aruny, MD Clemem]. Grassi, MDKevin Dickey, MD Stuart C. Geller, MDPamela Flick, MD Krishna Kandarpa, MD, PhDHal L. Folander, MD Richard Shlansky-Goldberg, MD

THROIVIBOlYSIS-VENOUS (35)Objectives: Upon completion of this workshop, theattendee should be able to:

1. Explain the role of thrombolysis in patients withileofemoral deep venous thrombosis and upperextremity venous occlusions, using the cur­rently available pharmacologic agents.

2. List the technical aspects of venous thromboly­sis, including delivery systems, dosing regimensand safe and effective protocols.

3. Discuss the potential role of adjunctive therapy,including heparin, GPlib/IIIa receptor inhibitorsand/or mechanical thrombectomy devices.

4. Discuss how to handle unusual or complex sit­uations that may arise during recanalization pro­cedures.

Coordinator: Murray]. Mazer, MD

Murray]. Mazer, MD David W. Humer, MDMatthew A. Mauro, MD Mark W. Mewissen, MDElvira v. Lang, MD Charles P. Semba, MD

P329